Robert Thong

Multidimensional Health Intelligence Platform for digital powered care delivery Mesh Bio is a fast growing digital health startup focused on addressing the growing challenges in care delivery. Mesh Bio develops AI powered clinical decision support, analytics and automation solutions for healthcare providers to transform healthcare delivery with digital solutions. At Mesh Bio, we actively build an environment for personal excellence and career growth. We encourage diversity of experiences/backgrounds and want team members to thrive in their domain of professional expertise.

Multiomic Health is a data-centric therapeutics venture, writing the latest chapter of the precision medicine story by tackling a global, trillion dollar healthcare problem: metabolic syndrome-related conditions (atherosclerotic cardiovascular disease, type 2 diabetes, chronic kidney disease and non-alcoholic fatty liver). Our mission is to transform patient health outcomes with precision medicines that go beyond the one-size-fits-all approach currently dominating this disease space. We apply advanced computational systems biology modelling and AI-enabled predictive analytics on deep, standardised patient datasets. These datasets feed into a data lake of thousands of patients, featuring millions of data points per patient accumulated from a wide spectrum of omics, rich clinical phenotyping and various tissue types collected over multiple time points. We use our proprietary MOHSAIC® platform to identify unique patient endotypes, re-position existing drug candidates and discover novel drug targets, leading to breakthrough precision therapeutics for the world’s largest patient population.

Multidimensional Health Intelligence Platform for digital powered care delivery Mesh Bio is a fast growing digital health startup focused on addressing the growing challenges in care delivery. Mesh Bio develops AI powered clinical decision support, analytics and automation solutions for healthcare providers to transform healthcare delivery with digital solutions. At Mesh Bio, we actively build an environment for personal excellence and career growth. We encourage diversity of experiences/backgrounds and want team members to thrive in their domain of professional expertise.

Selvedge Venture is a venture capital firm investing for impact in age-related medical conditions. We invest in platform technologies and interventions that are expected to transform patient outcomes in age-related medical conditions such as Metabolic Syndrome (Cardiovascular Disease, Diabetes, Fatty Liver Disease and Obesity), Oncology and Neurodegeneration. Selvedge Venture was founded by experienced professionals from the venture capital, healthcare, life science and pharmaceutical industries. We are backed by an investor base of family offices and high net worth individuals.

Novasecta empowers pharmaceutical and biotech leaders to achieve strategic and operational excellence. Our team provides the challenge, structure and urgency that leaders need to make a difference.